Document is current
Any future updates will be listed below
-
Authors
Angleitner, Alexander C.
Maulhardt, Markus
Thomson, Kristian
Büntzel, Judith
Wulf, Gerald
-
Funding
Funding for this research was provided by:
Herzzentrum Göttingen
- License Information
-
More Information
Article History
Received: 2 March 2026
Accepted: 16 May 2026
First Online: 26 May 2026
Declarations
:
: This study was approved by the Ethics Committee of the University Medical Center Göttingen, Germany (approval number 26/3/25). The study was conducted in accordance with the ethical principles of the Declaration of Helsinki and its later amendments. Due to the retrospective design of the study and the use of anonymized clinical data, the requirement for informed consent was waived by the ethics committee.
: Not applicable.
: The authors used ChatGPT (OpenAI) for language editing and stylistic improvement of the manuscript text. All scientific content, data interpretation, and final manuscript revisions were performed and approved solely by the authors.
: A.A. has received travel grants from Gilead and Menarini Stemline, outside the submitted work.M.M. has participated in advisory boards for Janssen and has received honoraria from AbbVie, AstraZeneca, Gilead, Janssen, and Lilly, outside the submitted work. M.M. has also received travel support from AbbVie, Gilead, Incyte, Janssen, Sobi, and Stemline. All other authors declare no competing financial interests.
